Los Angeles Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $802K | Sell |
1,631
-14,662
| -90% | -$7.96M | ﹤0.01% | 740 |
|
|
2025
Q4 | $9.06M | Buy |
16,293
+13,546
| +493% | +$7.66M | 0.03% | 241 |
|
|
2025
Q3 | $1.33M | Buy |
2,747
+594
| +28% | +$276K | ﹤0.01% | 617 |
|
|
2025
Q2 | $873K | Sell |
2,153
-1,613
| -43% | -$674K | ﹤0.01% | 687 |
|
|
2025
Q1 | $1.87M | Buy |
3,766
+311
| +9% | +$168K | 0.01% | 412 |
|
|
2024
Q4 | $1.8M | Sell |
3,455
-8,647
| -71% | -$4.75M | 0.01% | 471 |
|
|
2024
Q3 | $7.49M | Buy |
12,102
+6,459
| +114% | +$3.82M | 0.03% | 273 |
|
|
2024
Q2 | $3.12M | Buy |
5,643
+1,815
| +47% | +$1.04M | 0.01% | 377 |
|
|
2024
Q1 | $2.22M | Sell |
3,828
-18,115
| -83% | -$10.2M | 0.01% | 475 |
|
|
2023
Q4 | $11.6M | Sell |
21,943
-44,730
| -67% | -$21.7M | 0.04% | 250 |
|
|
2023
Q3 | $33.7M | Sell |
66,673
-145,163
| -69% | -$77.4M | 0.14% | 137 |
|
|
2023
Q2 | $111M | Buy |
211,836
+114,105
| +117% | +$61.6M | 0.44% | 53 |
|
|
2023
Q1 | $56.3M | Buy |
97,731
+82,853
| +557% | +$46.7M | 0.25% | 91 |
|
|
2022
Q4 | $8.19M | Buy |
14,878
+1,743
| +13% | +$924K | 0.04% | 308 |
|
|
2022
Q3 | $6.66M | Sell |
13,135
-44,171
| -77% | -$24.7M | 0.03% | 321 |
|
|
2022
Q2 | $31.1M | Sell |
57,306
-180,254
| -76% | -$99.2M | 0.15% | 139 |
|
|
2022
Q1 | $140M | Buy |
237,560
+5,708
| +2% | +$3.28M | 0.55% | 40 |
|
|
2021
Q4 | $155M | Buy |
231,852
+37,134
| +19% | +$23.2M | 0.58% | 35 |
|
|
2021
Q3 | $111M | Sell |
194,718
-17,140
| -8% | -$9.41M | 0.51% | 41 |
|
|
2021
Q2 | $107M | Sell |
211,858
-7,831
| -4% | -$3.69M | 0.47% | 46 |
|
|
2021
Q1 | $100M | Sell |
219,689
-813
| -0.4% | -$388K | 0.45% | 43 |
|
|
2020
Q4 | $103M | Sell |
220,502
-11,671
| -5% | -$5.47M | 0.44% | 43 |
|
|
2020
Q3 | $103M | Sell |
232,173
-6,114
| -3% | -$2.53M | 0.47% | 40 |
|
|
2020
Q2 | $86.3M | Buy |
238,287
+4,926
| +2% | +$1.65M | 0.42% | 55 |
|
|
2020
Q1 | $66.2M | Sell |
233,361
-43,085
| -16% | -$13.6M | 0.42% | 66 |
|
|
2019
Q4 | $89.8M | Sell |
276,446
-27,903
| -9% | -$8.46M | 0.45% | 60 |
|
|
2019
Q3 | $88.6M | Sell |
304,349
-10,232
| -3% | -$2.93M | 0.48% | 50 |
|
|
2019
Q2 | $92.4M | Buy |
314,581
+25,390
| +9% | +$6.99M | 0.5% | 43 |
|
|
2019
Q1 | $79.2M | Buy |
289,191
+58,720
| +25% | +$14.6M | 0.44% | 54 |
|
|
2018
Q4 | $51.6M | Buy |
230,471
+1,610
| +0.7% | +$378K | 0.32% | 79 |
|
|
2018
Q3 | $55.9M | Buy |
228,861
+15,944
| +7% | +$3.67M | 0.29% | 82 |
|
|
2018
Q2 | $44.1M | Sell |
212,917
-4,471
| -2% | -$949K | 0.24% | 103 |
|
|
2018
Q1 | $44.9M | Sell |
217,388
-12,497
| -5% | -$2.62M | 0.25% | 109 |
|
|
2017
Q4 | $43.7M | Sell |
229,885
-10,841
| -5% | -$2.08M | 0.24% | 113 |
|
|
2017
Q3 | $45.5M | Buy |
240,726
+171,184
| +246% | +$31M | 0.26% | 102 |
|
|
2017
Q2 | $12.1M | Buy |
69,542
+64,191
| +1,200% | +$10.8M | 0.08% | 285 |
|
|
2017
Q1 | $822K | Sell |
5,351
-2,285
| -30% | -$349K | 0.01% | 773 |
|
|
2016
Q4 | $1.08M | Sell |
7,636
-101,825
| -93% | -$15M | 0.01% | 690 |
|
|
2016
Q3 | $17.4M | Sell |
109,461
-5,563
| -5% | -$857K | 0.15% | 194 |
|
|
2016
Q2 | $17M | Sell |
115,024
-100
| -0.1% | -$14.8K | 0.14% | 181 |
|
|
2016
Q1 | $16.3M | Sell |
115,124
-43,212
| -27% | -$5.79M | 0.15% | 174 |
|
|
2015
Q4 | $22.5M | Buy |
158,336
+13,220
| +9% | +$1.76M | 0.21% | 135 |
|
|
2015
Q3 | $17.7M | Sell |
145,116
-3,190
| -2% | -$416K | 0.17% | 168 |
|
|
2015
Q2 | $19.2M | Sell |
148,306
-3,199
| -2% | -$417K | 0.18% | 165 |
|
|
2015
Q1 | $20.4M | Sell |
151,505
-9,211
| -6% | -$1.19M | 0.19% | 152 |
|
|
2014
Q4 | $20.1M | Buy |
160,716
+54,347
| +51% | +$6.61M | 0.19% | 146 |
|
|
2014
Q3 | $12.9M | Sell |
106,369
-22,487
| -17% | -$2.73M | 0.16% | 166 |
|
|
2014
Q2 | $15.2M | Buy |
128,856
+10,219
| +9% | +$1.2M | 0.15% | 189 |
|
|
2014
Q1 | $14.3M | Buy |
118,637
+3,399
| +3% | +$404K | 0.16% | 180 |
|
|
2013
Q4 | $12.8M | Sell |
115,238
-47,078
| -29% | -$4.68M | 0.14% | 198 |
|
|
2013
Q3 | $15M | Buy |
162,316
+5,975
| +4% | +$540K | 0.18% | 160 |
|
|
2013
Q2 | $13.2M | Buy |
+156,341
| New | +$13M | 0.19% | 148 |
|
Other funds holding TMO
VCM
Los Angeles Capital Management's TMO Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 90% in Q1 2026, selling an estimated $7.96M and leaving 1,631 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #740.
Los Angeles Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $155M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Los Angeles Capital Management held 1,631 shares of Thermo Fisher Scientific worth $802K as of Q1 2026.
- Los Angeles Capital Management sold 14,662 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.96M.
- Thermo Fisher Scientific made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #740 holding.
- Los Angeles Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Los Angeles Capital Management's Thermo Fisher Scientific position peaked at $155M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.